Narender Singh is a group leader of the Multiscale Biomedical Systems Group at Oak Ridge National Laboratory. He is part of the University of Tenneessee-Oak Ridge Innovation Institute’s Radiopharmaceutical Therapies Convergent Research Initiative. 

His research focuses on developing innovative biomedical solutions for military and public health applications. His research has received funding from organizations including the Air Force (AF), Defense Threat Reduction Agency (DTRA), ChemBio Defense (CB), Food and Drug Administration (FDA), and various pharmaceutical companies.

Before joining ORNL, Narender served as a group leader at CFD Research in Huntsville, AL. Prior to his time at CFD Research, he worked at the Department of Defense’s Biotechnology HPC Software Applications Institute in Frederick, Maryland. He brings over 15 years of experience working collaboratively across academia, government, and regulatory sectors, specializing in interdisciplinary research that integrates physical, computational, and life sciences.

Education